BRPI0510328A - macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas - Google Patents
macrolìdeos ligados a éster úteis para o tratamento de infecções microbianasInfo
- Publication number
- BRPI0510328A BRPI0510328A BRPI0510328-2A BRPI0510328A BRPI0510328A BR PI0510328 A BRPI0510328 A BR PI0510328A BR PI0510328 A BRPI0510328 A BR PI0510328A BR PI0510328 A BRPI0510328 A BR PI0510328A
- Authority
- BR
- Brazil
- Prior art keywords
- ester
- treatment
- microbial infections
- useful
- linked
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
- 229940041033 macrolides Drugs 0.000 title abstract 2
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56940204P | 2004-05-06 | 2004-05-06 | |
| US58111804P | 2004-06-18 | 2004-06-18 | |
| PCT/IB2005/001186 WO2005108412A1 (en) | 2004-05-06 | 2005-05-02 | Ester linked macrolides useful for the treatment of microbial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0510328A true BRPI0510328A (pt) | 2007-10-23 |
Family
ID=34967616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0510328-2A BRPI0510328A (pt) | 2004-05-06 | 2005-05-02 | macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080255060A1 (https=) |
| EP (1) | EP1756135B1 (https=) |
| JP (1) | JP2007536371A (https=) |
| AR (1) | AR049269A1 (https=) |
| AT (1) | ATE439367T1 (https=) |
| AU (1) | AU2005240849B2 (https=) |
| BR (1) | BRPI0510328A (https=) |
| CA (1) | CA2566085A1 (https=) |
| DE (1) | DE602005015963D1 (https=) |
| ES (1) | ES2331739T3 (https=) |
| IL (1) | IL178876A0 (https=) |
| MA (1) | MA28640B1 (https=) |
| MX (1) | MXPA06012923A (https=) |
| NO (1) | NO20065662L (https=) |
| RU (1) | RU2006143051A (https=) |
| WO (1) | WO2005108412A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2552682T3 (es) | 2003-03-10 | 2015-12-01 | Merck Sharp & Dohme Corp. | Agentes antibacterianos novedosos |
| JP2008540503A (ja) | 2005-05-10 | 2008-11-20 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | 細菌感染症の処置に有用なエーテル結合マクロライド |
| KR101120483B1 (ko) * | 2006-12-05 | 2012-02-29 | 브리스톨-마이어즈 스퀴브 컴페니 | 모틸라이드 다형체 |
| CN105732745A (zh) | 2007-10-25 | 2016-07-06 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
| AU2009308182B2 (en) | 2008-10-24 | 2016-05-19 | Cempra Pharmaceuticals, Inc. | Biodefenses using triazole-containing macrolides |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| US9480679B2 (en) | 2009-09-10 | 2016-11-01 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| CN105198944B (zh) | 2010-05-20 | 2018-06-01 | 森普拉制药公司 | 制备大环内酯和酮内酯及其中间体的方法 |
| EP2613630A4 (en) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES |
| MX2014011537A (es) | 2012-03-27 | 2015-02-10 | Cempra Pharmaceuticals Inc | Formulaciones parenterales para la administracion de antibioticos macrolidos. |
| HK1217665A1 (zh) | 2013-03-14 | 2017-01-20 | 森普拉制药公司 | 用於治療呼吸道疾病的方法及其製劑 |
| RU2015138797A (ru) | 2013-03-15 | 2017-04-24 | Семпра Фармасьютикалс, Инк. | Конвергентные способы получения макролидных антибактериальных агентов |
| GB201608236D0 (en) | 2016-05-11 | 2016-06-22 | Fidelta D O O | Seco macrolide compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0127349D0 (en) * | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
| GB0225384D0 (en) * | 2002-10-31 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
| GB0310984D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| SI1628989T1 (sl) * | 2003-05-13 | 2007-06-30 | Glaxo Group Ltd | Nove cikliäśne spojine s 14 in 15 obroäśnimi äśleni |
| GB0310979D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| JP2008540503A (ja) * | 2005-05-10 | 2008-11-20 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | 細菌感染症の処置に有用なエーテル結合マクロライド |
-
2005
- 2005-05-02 BR BRPI0510328-2A patent/BRPI0510328A/pt not_active IP Right Cessation
- 2005-05-02 ES ES05739739T patent/ES2331739T3/es not_active Expired - Lifetime
- 2005-05-02 WO PCT/IB2005/001186 patent/WO2005108412A1/en not_active Ceased
- 2005-05-02 AU AU2005240849A patent/AU2005240849B2/en not_active Ceased
- 2005-05-02 AT AT05739739T patent/ATE439367T1/de not_active IP Right Cessation
- 2005-05-02 CA CA002566085A patent/CA2566085A1/en not_active Abandoned
- 2005-05-02 MX MXPA06012923A patent/MXPA06012923A/es unknown
- 2005-05-02 EP EP05739739A patent/EP1756135B1/en not_active Expired - Lifetime
- 2005-05-02 US US11/568,562 patent/US20080255060A1/en not_active Abandoned
- 2005-05-02 RU RU2006143051/04A patent/RU2006143051A/ru not_active Application Discontinuation
- 2005-05-02 JP JP2007512549A patent/JP2007536371A/ja not_active Withdrawn
- 2005-05-02 DE DE602005015963T patent/DE602005015963D1/de not_active Expired - Lifetime
- 2005-05-04 AR ARP050101810A patent/AR049269A1/es not_active Application Discontinuation
-
2006
- 2006-10-26 IL IL178876A patent/IL178876A0/en unknown
- 2006-12-01 MA MA29498A patent/MA28640B1/fr unknown
- 2006-12-06 NO NO20065662A patent/NO20065662L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20065662L (no) | 2007-01-16 |
| EP1756135B1 (en) | 2009-08-12 |
| IL178876A0 (en) | 2007-03-08 |
| AU2005240849A1 (en) | 2005-11-17 |
| EP1756135A1 (en) | 2007-02-28 |
| ATE439367T1 (de) | 2009-08-15 |
| US20080255060A1 (en) | 2008-10-16 |
| JP2007536371A (ja) | 2007-12-13 |
| CA2566085A1 (en) | 2005-11-17 |
| MA28640B1 (fr) | 2007-06-01 |
| AR049269A1 (es) | 2006-07-12 |
| ES2331739T3 (es) | 2010-01-14 |
| DE602005015963D1 (de) | 2009-09-24 |
| WO2005108412A1 (en) | 2005-11-17 |
| AU2005240849B2 (en) | 2008-10-23 |
| RU2006143051A (ru) | 2008-06-20 |
| MXPA06012923A (es) | 2007-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0116431A (pt) | Antibióticos de macrolìdeos | |
| BRPI0510328A (pt) | macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas | |
| BR0214132A (pt) | Composto, processo para a preparação e uso do mesmo, composição farmacêutica, e, método para o tratamento do organismo animal humano ou não humano para combater infecção bacteriana | |
| BR0316169A (pt) | Derivados de indolil pirazinona úteis para tratamento de distúrbios e doenças hiperproliferativos associados com angiogênese | |
| BR0112395A (pt) | Derivados de benzotiazol | |
| BR112013028813A2 (pt) | derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas | |
| BR0213522A (pt) | Composto, composição farmacêutica, métodos de inibir a hiv integrase e para prevenir ou tratar a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids em um paciente, e, combinação útil para tratar ou prevenir a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids | |
| BRPI0514536A (pt) | uso de oligossacarìdeos não-digerìveis e sacarìdeo de galactose digerìvel, e, composição adequada para o tratamento e/ou prevenção de infecções do trato respiratório e/ou doença de infecção do trato respiratório | |
| DE60123277D1 (de) | Makrolidantibiotika | |
| NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
| NO20064201L (no) | Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling | |
| ECSP088902A (es) | Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios | |
| UY26269A1 (es) | Formulación de sal común y moxifloxacina | |
| UA94901C2 (ru) | Антибактериальные производные пиперидина | |
| BR0112571A (pt) | Método para o tratamento de fêmeas humanas, composição farmaceuticamente aceitável e dispositivo para aplicação intravaginal ou transvaginal de um agente farmacêutico antifúngico, antiviral, antibacteriano ou parasiticida | |
| BR0210075A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa | |
| BRPI0509140A (pt) | processos para o tratamento de infecção por hiv | |
| BR0115045A (pt) | Compostos, processo para sua preparação, composição farmacêutica que compreende os mesmos, sua utilização, processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade | |
| BR0309757A (pt) | 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases | |
| BR0215016A (pt) | Piridoquinoxalinas antivirìcas | |
| NO20092655L (no) | 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler | |
| WO2007075695A3 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| BR0209206A (pt) | Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo | |
| WO2004039822A3 (en) | 4’’ - modified erythromycin derivatives | |
| ATE275405T1 (de) | Sucralfat enthaltendes arzneimittel zur behandlung von zervikale erosion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |